Similar Articles
1221 Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
1222 Diuretic window hypothesis in cirrhosis: Changing the point of view
1223 International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy
1224 Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
1225 Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
1226 Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
1227 Surgery with adjuvant or neoadjuvant treatment vs surgery alone for resectable pancreatic cancer: A network meta-analysis
1228 Immunotherapy for hepatocellular carcinoma: Current and future
1229 Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
1230 Hepatocellular carcinoma – time to take the ticket
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA